Aiming for More Growth

Results of Operations for the

Fiscal Year Ended March 31, 2014

April 30, 2014

Nihon Trim Co., Ltd.

The information, forecasts, etc. available in this material are the Company’s judgment as of the preparation date thereof and do not

always guarantee the accuracy of these information. Further, the Company and the information provider will not be responsible for

any damages incurred according to these information. * The material is not prepared for the purpose of soliciting investments.

IR Contact: Business Strategy & Management Dept. (TEL: +81-(0)6-6456-4633 E-mail: ir@nihon-trim.co.jp)

Contents

2

1. Overview of the Nihon Trim Group Business

2. Business Performance, Forecast, Indices, etc.

3. Supplementary Materials

Pages 3 - 19

Pages 20 - 28

Pages 29 - 36

3

1. Overview of the Nihon Trim Group Business

FY3/14 Topics

4

❑ Sales and profits higher for five consecutive fiscal years

❑ Record-high earnings

❑ Rapid growth in the genetic diagnosis sector makes a big contribution to

earnings

❑ The Federation of Diet Members to Promote the Use of Highly Functional

Water was established (May 2013)

❑ Japan’s largest private cord blood bank became a consolidated subsidiary

(September 2013)

❑ Started OEM business with a major home appliance manufacturer

(December 2013)

5

❑ Full-scale start of operations with the sales company of a major home appliance

manufacturer

❑ Concentrating on business activities involving cancer-related genetics in the

genetic diagnosis business.

� Plan to submit an application in Japan for an external diagnostic drug

� Plan to receive CE mark certification to start operations in Europe and China

❑ Many activities for increasing the number of cord blood held at the cord blood

bank

❑ Plan to conduct human tests for the purpose of confirming the benefits of

Electrolyzed hydrogen water (EHW) regarding metabolic syndrome

❑ Expect to install electrolyzed water hemodialysis systems at four new locations

and will work on further expanding the use of these systems

❑ Agriculture: Started full-scale cultivation of reduced vegetables in May 2014 in a

1,300m2 greenhouse

❑ Using an alliance with a company in China to expand operations in this country

FY3/15 Topics

The Business Goals of the Nihon Trim Group

6

❑ Use highly functional water

❑ Help the people of Japan lead healthy lives

❑ Become an important industry for health care, agriculture and industry sectors

❑ Utilize technologies created in Japan

Transform from a household appliance supplier into a medical company

Positioning the Nihon Trim Group as a supplier of medical devices will also help

increase sales of household EHW systems.

• MGO measurement (TMI)

• Mutated gene detection kits (TRIMGEN)Prediction

• EHW (drinking EHW system)

• Reduced Vegetables

(EHW system for vegetables/functional crops)Prevention

• Electrolyzed water hemodialysis (EW-HD system)

• EHW (drinking EHW system)

• Cord blood bank (StemCell Institute)Treatment

Aiming for good

health and a long life

Lower health care

expenses

Realization of a Water Health Care Society

7

日本日本日本日本トリムトリムトリムトリム

1. About 5% of Japan’s approximately 50 million households use EHW systems

(water purifier ownership rate is about 40%)

2. Goal is to increase EHW system use to 20% by raising awareness of its benefits and performing research

to identify new uses for EHW

Benefit: Improve condition of stomach and intestines

50 million households x 20% (a) Improves health (b) Low costnote1 (c) Ecology

= 10 million households

3. Nihon Trim anticipates a market share of 30%

10 million households x 30% = 3 million households

(a) Equipment sales (one-by-one sales):

Total market for purifiers is ¥1 trillion = ¥300 billion (30% share)

(b) Replacement cartridges (consistent sales):

Purification cartridge sales of ¥20 billion/year

(assuming a 70% replacement ratio)

4. Global expansion by using the “functional water business,” a technology that originated in Japan

Note 1: Approx. 7 yen per liter when using TRIM ION HYPER for five years

and replacing the cartridge once each year

59.4%

14.9%

9.7%

1.0%

0.4% 0.1% 14.5%

Nihon Trim

Others

Company A

Company E

Company B

Company D

Company C

❑ Today, people want water with both “quantity” and “quality” (functions)

❑ Health care: Prevention to reduce treatment and nursing home care

Preventing diseases lowers health care expenses

Goal is to sell 3 million units of the EHW System!!

Source: Yano Research Institute

“2014 White Paper on Water Purifiers/Water Conditioners”

To Raise Utilization to 3 Million Units of EHW Systems

8

1. Demonstrate effectiveness regarding lifestyle

diseases

2. Launch of next-generation products

3. Strengthen promotional activities and improve

ratio of purchase decisions

4. Strengthen R&D activities at the industrial,

public and academic sectors

Demonstrate Effectiveness Regarding

Lifestyle Diseases

9

0

100

200

300

400

500

600

Blo

od

tri

gly

ceri

de

le

ve

l (m

g/d

l)

Blood triglyceride level

Before

consumption

After

consumption

0

50

100

150

200

250

300

350

400

Blo

od

su

ga

r le

ve

l (m

g/d

l)

Blood sugar level

Before

consumption

After

consumption

Human tests for drinking EHW

Announce results using symposiums

and research papers

Increase the use of EHW systems

Starting large-scale tests in the current fiscal yearStarting large-scale tests in the current fiscal year

Example of completed EHW testExample of completed EHW test

Experiment for benefits of drinking EHW Joint research with Kitano Hospital of the Tazuke Kofukai Medical Research Institute

Individuals used EHW as ordinary drinking water for at least 60 days with the goal of drinking about 2,000ml every day.

(1) Blood triglyceride level (normal range: 45-150mg/dl)

Among the individuals who used EHW, 11 of the 12 people

who had elevated blood triglyceride levels saw these levels

decline and the level decreased to normal for two people.

(2) Blood sugar level (normal range: 70 -109mg/dl)

Among the individuals who used EHW, all of the 11 people

who had elevated blood sugar levels saw these levels

decline and the level decreased to normal for eight people.

This research is currently in the verification phase and the data shown here are

pilot figures showing that the desired effect may be achieved. These figures are

not a guarantee of effectiveness.

Launch of Next-generation Products

10

“Compact”

“Digital display for dissolved hydrogen density (approximate)”

“Better cartridge performance”

Standard price in Japan (with tax): 177,120 yen

(Medical equipment manufacture

certification number: 226AGBZX00012000)

Benefit:

Improve condition of stomach and intestines

� Removes 13 JIS-designated compounds*1 and three compounds*2 in

JWPA voluntary standards!■ Used cartridges are

collected and

recycled at no charge!

Can be installed almost anywhere thanks to its stylish and compact design.

Compared with NEO, volume is about 18% smaller and the area needed for

installation is about 15% smaller.

When the unit produces EHW, the display shows the approximate level of

dissolved hydrogen in the water in ppb. A patent is pending for this capability

that no other company offers.

In addition to the 13 JIS-designated compounds removed by the previous

cartridge, this new cartridge removes three compounds in the voluntary

standards of the Japan Water Purifier Association (JWPA). Furthermore, each

cartridge can purify 8,000 liters of water compared with 7,000 liters for the NEO

cartridge.

Microcarbon Cartridges

Filtering capacity of water purification cartridges�Removable Materials (Total Filtered Water: 8 tons total) (Test Filter Quantity: 3L/min)

*1: 13 JIS-designated compounds 5 Bromodichloromethane 10 1,1,1-trichloroethane

1 Free residual chlorine 6 Dibromochloromethane 11 CAT (agricultural chemical)

2 Turbidity 7 Bromoform 12 2-MIB (odor of mold)

3 Total trihalomethan*3 8 Tetrachloroethylene 13 Soluble lead

4 Chloroform 9 Trichloroethylene

*3: Total trihalomethan" is the sum of the amount of materials 4 to 7.

(a) Nonwoven fabric

(b) Microcarbon

Water entrance (tap water)

Water discharge

(pure water)

*2: 3 JWPA voluntary

standard compounds

1 Geosmin (odor of mold)

2 Phenols

3 Anionic surfactants

Strengthen Promotional Activities and

Improve Ratio of Purchase Decisions

11

Since December 2013

Launched Website providing information

on locations where people can drink EHW

Information on the 35 locations throughout

Japan where people can select menu items

that incorporate EHW or drink EHW.

facebook twitterYouTube Staff blogManufacturing subsidiary

created its own website

February 2014

Water Awareness Survey

An Internet survey was performed on February 22 and 23, 2014 to

gather information from 400 married women between the ages of 20

and 59 about their views of water for drinking and cooking at home and

how they use water.

May 2013

“Father-Child Cooking Class” for Mother’s Day

Fathers and children prepared meals

together for mothers in an event held with

the Shokuryo Gakuin (Food Academy).

August 2013

Gutta Ri-Man (“Exhausted business people”)

Rescue Project

This project supports the heat stroke

prevention project of the Ministry of the

Environment and Ministry of Health, Labour

and Welfare. Nihon Trim set up a water

distribution and relaxation space in Tokyo’s

Marunouchi district to provide EHW and

shaved ice at no cost to office workers.

Cool Off Award 2013

Received Award for Excellence

Started October 2013

“Project Sugoi-ne! Go-Tochi Kyaraben!” TV Program

A nationwide TV program for making lunch box meals with the faces of local

characters (Started October 8; broadcast on CS Sky A Sports+, sponsored

solely by Nihon Trim)

“Bary-san” from the city of Imabari

won the 2012 Grand Prix

Strengthen R&D Activities at the Industrial,

Public and Academic Sectors

12

[Basic Research Field] - Identifying the mechanism for the benefits of EHW

(2) School of Agriculture, Kyushu University

(1) Karolinska Institute (Sweden)

Department of Neuroscience

[Medical/Preventive Medical Care Field] - Applied for hemodialysis (clinical

study)

[Agricultural Production Field] - Confirm the benefits of EHW on crops and

develop an agricultural EHW system

(Japan)

[The Federation of Diet Members to Promote the Use of Highly Functional Water]

Established in May 2013

(3) Fukushima Medical University

(4) School of Medical Science, Tohoku University/

Kashima Hospital (Fukushima)/Nikko Memorial Hospital (Hokkaido), etc.

(5) Department of Surgery, Kochi Medical School

(Overseas)

(6) Clinical Laboratory Sciences and Medical Biotechnology,

National Taiwan University (Taiwan)

(7) Karolinska University Hospital (Sweden)

(8) Faculty of Agriculture and Agricultural Science Program,

Kochi University

(9) Faculty of Agriculture, Kyoto Prefectural University/

Kyoto Prefectural University of Medicine

Tohoku University Hospital

Karolinska University Hospital

Hemodialysis Ward

Main component EHW Tap water

α-carotene (μg/100g) 7 5

B-carotene (μg/100g) 780 750

Lycopene (mg/100g) 10 9

Sugar content (%) 8.2 7.6

13

Reduced vegetable production has started

at this large greenhouse.

1. Started full-scale cultivation of reduced vegetables in a large 1,300m2 greenhouse in May 2014.

2. Established regional alliances and cooperative frameworks that include industrial, academic and public-sector partners

Kochi Prefecture (confirmed higher revenues and value added), JA Nankoku City (production, distribution, marketing)

Kochi University Faculty of Agriculture (identified physical properties and mechanism of water; confirmed anti-oxidant

properties of crops)

3. Signed an industrial promotion agreement to cooperate with the City of Nankoku in Kochi prefecture and made an investment in

Nishijima Flower Garden Co., Ltd. It conducts demonstration cultivation of reduced vegetables

4. Reduced vegetables were exhibited at Kochi Kodawari Produce Market in Osaka 2014 and generated substantial interest among

department store buyers and vegetable sommeliers

Yield EHW Tap water

Weight (grams) 575 455

No. of tomatoes 66 59

Weight per tomato (grams) 8.7 7.7

High volume of anti-oxidants (B-carotene, lycopene) with EHW

EHW yields a larger volume and higher weight per tomato

❑ EHW allows growing highly functional plants with higher yields and large amounts of anti-

oxidants

❑ A grower-processor-distributor framework has been established by using alliances with an

agricultural products company and a large retailer

❑ Used at plant factories

Tomatoes Grown with

EHW vs. Tap Water

EHW (pH10)

EHW (pH10)

Tap water

Tap water

Agriculture: Reduced Vegetables (Trademark)

[Analysis by Japan Food Hygiene Association]

Overseas: Indonesia (Bottling business)

14

� Participating in a joint business venture with a local conglomerate called the Sinarmas Group

� Profitable for three consecutive years

� Japanese embassy, consulate general, JAL Narita-Jakarta, hotels, Starbucks Coffee, Seven-Eleven, etc.

� Exports to Singapore

� Environmental protection activities through an alliance with Taman Nasional Gunung Gede Pangrango

(National Park)

� Sustainable growth backed by an expanding middle-class in a country with the world’s fourth-largest population

and a growing economy

� Plan to add another production line that incorporates even more advanced technologies

Local brand “Prestine”

Overseas: China/Taiwan (EHW systems sales)

15

China:

Taiwan:

� Many actions are under way for growth; considering an alliance with a company in China

� Operations are still small but are growing steadily

� Using the sales channels of the alliance partner, a distributor of medical products, and

branding through joint research with Taiwan University with the aim of enlarging sales

channels for EHW systems

� Increasing the number of sales agents in Taiwan

Guangzhou Trim website Taiwan showroom

Genetic Diagnosis (Individualized treatments)

16Mutector II (Mutated gene detection kit) WaxFree (FFPE gene extraction kit)

❑ R&D for mutated gene detection kits and gene extraction kits; goal is to expand

manufacturing and sales operations and grow on a global scale� Use exclusive technologies for R&D, manufacturing and sales for genetic testing kits

� Use individualized treatments for drug selection in order to reduce side effects; lowers cost

of treatment and risk of accidents involving treatment

FY3/14

1. Rapid growth in TrimGen Holdings Co., Ltd.: Results for FY3/14: net sales ¥619 million; operating income ¥467 million

(Reference: FY3/13 net sales ¥136 million; operating income ¥50 million)

2. Office was opened in Osaka for the purposes of building a stronger base for sustained growth, expanding into the

Japanese market, and listing its stock in Japan in the near future.

3. Developed new product with a clinical study company

Genetic Diagnosis: Forecast for FY3/15

17

<TrimGen earnings forecast>

(Millions of yen) FY3/14 Results FY3/15 Forecast

Net sales 619 150

Gross profit 575 128

SG&A expenses 108 188

Operating income 467 -60

Ordinary income 677 -81

FY3/15

1. Uncertainty about transactions for warfarin sensitivity kits with a clinical study company, which contributed to growth in FY3/14a) Tests are mostly completed with regard to trials with the U.S. FDA concerning the effectiveness of genetic tests prior to administering

warfarin

b) Use in FDA tests demonstrates the advanced technologies and reliability of TrimGen products

c) Tests results showed that requiring genetic tests prior to administering warfarin is possible = Raises expectations for rapid growth of

this market

2. Concentrate on growth in the original core market of genetic testing involving cancera) Applied in Japan for approval of external diagnostic drug = Started clinical trial with Mie University in December 2013

b) Aim to acquire CE mark certification for starting operations in Europe and China

3. Take steps involving capital, internal controls and other items to prepare for the IPO in Japan of TrimGen Holdings.

These actions will raise expenses.

a) Recruit more employees to strengthen R&D, sales and administrative activities

b) Expenses for audits and other activities to prepare for the IPO

4. Foreign exchange gains of ¥204 million was recorded in FY3/14. In FY3/15, we estimate foreign exchange loss of ¥25 million.

�Start activities involving cancer-related genetic operations

�To prepare for the IPO, infrastructure will be strengthened while expenses will increase

Electrolyzed Water Hemodialysis

18

[Sales and Promotions]

1. Plan to install electrolyzed water hemodialysis systems at four new locations

2. A sales agent agreement has been signed with Nikkiso Co., Ltd. to co-promote sales promotion activities (15 hospitals/190

beds at the end of April 2014)

3. The 7th Electrolyzed Water Hemodialysis Study Group meeting, which was hosted by the Association of Electrolyzed Water-

Hemodialysis (EW-HD) Study Group, was held on February 1, 2014

[R&D]

1. R&D project has started with subsidies of about ¥230 million(The Japan Science and Technology Agency and the Fukushima Prefecture Medical and Welfare Equipment Development Project)

2. Selected as one of the sessions for next-generation dialysis treatment methods at the Japanese Society for Dialysis Therapy

(Fukuoka, June 2013)

3. Clinical research with Karolinska Institute (Sweden) is currently underway

❑ A revolutionary treatment method that targets the high volume of water used for dialysis (patented)

❑ Using a dialysis fluid that includes hydrogen improves patients’ quality of life by reducing oxidation stress,

inflammations and side effects

Example of an electrolyzed water hemodialysis

system for many dialysis patients

A medical institution that uses

electrolyzed water hemodialysis

7th Electrolyzed Water Hemodialysis

Study Group Meeting

Regenerative Medicine

1919

1. StemCell Institute became a consolidated subsidiary in September 2013

Nihon Trim’s consolidated FY3/14 results include six months of StemCell Institute earnings

(sales of ¥312 million and operating income of ¥47 million)

Amortization of goodwill: about ¥34 million / year (six months of amortization in FY3/14)

2. There is much growth potential for Japan’s cord blood storage market while the storage ratio in

Japan is still low.[Cord blood storage ratio for newborns]

Japan (1 million): 0.4% USA (3.8 million): 7%

South Korea (0.49 million): 12% Taiwan (0.2 million): 5%

*Numbers in parentheses are annual births

[Uses of Cord Blood]

1. For the treatment of diseases [hematopoietic stem cell transplant]

Leukemia (brothers-sisters)/ Aplastic anemia (donor, brothers-sisters), and others

2. For diseases at the clinical trial stage (overseas) [regenerative medicine and

cellular therapy]

Cerebral palsy / Hypoxic-ischemic encephalopathy, and others

3. For diseases at the R&D stage (overseas, Japan) [regenerative medicine and

cellular therapy]

Chronic pneumonitis / Parkinsonian tremor / Cerebral infarction, and others

[Uses of Cord Blood]

1. For the treatment of diseases [hematopoietic stem cell transplant]

Leukemia (brothers-sisters)/ Aplastic anemia (donor, brothers-sisters), and others

2. For diseases at the clinical trial stage (overseas) [regenerative medicine and

cellular therapy]

Cerebral palsy / Hypoxic-ischemic encephalopathy, and others

3. For diseases at the R&D stage (overseas, Japan) [regenerative medicine and

cellular therapy]

Chronic pneumonitis / Parkinsonian tremor / Cerebral infarction, and others

❑ The long-term storage service of cord blood in anticipation of its use in regenerative medicine and

cellular therapy and for treating future diseases

❑ StemCell Institute Inc. is Japan’s largest private cord blood bank (31,132 individuals as of March 2014)

20

2. Business Performance, Forecast, Indices, etc.

FY3/14 Results: Consolidated Statement of Income

21

Amount % Amount %

Net sales 10,690 100.0% 13,144 100.0% 2,454 23.0%

Cost of sales 2,357 22.0% 2,987 22.7% 630 26.7%

Gross profit 8,333 78.0% 10,157 77.3% 1,824 21.9%

SG&A expenses 6,149 57.5% 7,043 53.6% 894 14.6%

Operating income 2,184 20.4% 3,114 23.7% 930 42.6%

Non-operating income 290 2.7% 398 3.0% 108 37.2%

Non-operating expenses 34 0.3% 70 0.5% 36 99.9%

Ordinary income 2,440 22.8% 3,442 26.2% 1,002 41.1%

Extraordinary income - - 143 1.1% 143 -

Extraordinary losses - - 42 0.3% 42 -

Income before income taxes 2,440 22.8% 3,543 27.0% 1,103 45.2%

Income taxes 906 8.5% 1,001 7.6% 95 10.5%

Minority interest in income 8 0.1% 35 0.3% 27 353.2%

Net income 1,526 14.3% 2,507 19.1% 981 64.3%

Net income per share 117.38 yen 65.5%

Change

(Amount)

Change

(%)

179.31 yen 296.69 yen

(Millions of yen)FY3/13 Results FY3/14 Results

Note: The Company conducted a 2-for-1 common stock split on October 1, 2013.

Net income per share for FY3/13 and FY3/14 have been adjusted to reflect the stock split.

FY3/14 Results: Sales by Business Segment

22

Amount % Amount %

(Flow-type business)

DS Division (workplace sales) 4,335 40.6% 4,536 34.5% 201 4.6%

HS Division (installation and referral sales) 1,342 12.6% 1,700 12.9% 358 26.7%

SS Division (store event sales) 595 5.6% 716 5.4% 121 20.3%

MS Division (OEM and wholesale sales) 694 6.5% 1,079 8.2% 385 55.4%

Operations Division (after-sales services) 274 2.6% 284 2.2% 10 3.7%

EHW systems sales, total 7,240 67.7% 8,315 63.3% 1,075 14.8%

(Stock-type business)

Cartridges 2,649 24.8% 3,062 23.3% 413 15.6%

(Sales at subsidiaries)

TRIM (Guangzhou) Water & Health Co., Ltd. 34 0.3% 51 0.4% 17 54.3%

PT.SUPER WAHANA TEHNO 246 2.3% 254 1.9% 8 3.8%

(Others) 370 3.5% 489 3.7% 119 31.8%

Total 10,539 98.6% 12,171 92.6% 1,632 15.5%

Genetic diagnosis 137 1.3% 619 4.7% 482 353.1%

Regenerative medicine - - 312 2.4% 312 -

Electrolyzed water hemodialysis and

MGO measurement14 0.1% 42 0.3% 28 192.3%

Total 151 1.4% 973 7.4% 822 545.7%

10,690 100.0% 13,144 100.0% 2,454 23.0%

Change

(%)(Millions of yen)

Me

dic

al

Bu

sin

ess

Consolidated, total

FY3/13 Results FY3/14 Results Change

(Amount)

Wa

te

r H

ea

lth

ca

re

Bu

sin

ess

A Healthy Financial Condition (Consolidated)

23

(Millions of yen) As of Mar. 31, 2013 As of Mar. 31, 2014

Current assets 10,612 14,365

A: Cash and deposits 6,224 8,914

B: Accounts receivable-

installment2,460 2,721

A+B: Total 8,684 11,635

Non-current assets 5,072 5,631

Total assets 15,684 19,997

Percentage of current assets:

81.0%

* Listed-company average: 36.2%(Refer to the aggregate summary of financial results for the fiscal

year ended March 31, 2013 on the Tokyo Stock Exchange website)

(Millions of yen) As of Mar. 31, 2013 As of Mar. 31, 2014

Total assets 15,684 19,997

Net assets 12,330 14,906

Equity ratio 78.6% 74.5%

Declined 4.1% due to the

inclusion of StemCell Institute

as a consolidated subsidiary

For StemCell Institute, 10 years of

storage fees are received when a

contract is signed. As a result,

unearned revenue and long-term

unearned revenue increase, which

causes the equity ratio to

decrease. However, liabilities

include no obligations that must be

repaid.

FY3/15 Forecast: Consolidated Statement of Income

24

Amount % Amount %

Net sales 13,144 100.0% 14,000 100.0% 856 6.5%

Cost of sales 2,987 22.7% 3,430 24.5% 443 14.8%

Gross profit 10,157 77.3% 10,570 75.5% 413 4.1%

SG&A expenses 7,043 53.6% 7,520 53.7% 477 6.8%

Operating income 3,114 23.7% 3,050 21.8% -64 -2.1%

Non-operating income 398 3.0% 130 0.9% -268 -67.3%

Non-operating expenses 70 0.5% 50 0.4% -20 -28.6%

Ordinary income 3,442 26.2% 3,130 22.4% -312 -9.1%

Extraordinary income 143 1.1% - - -143 -

Extraordinary losses 42 0.3% - - -42 -

Income before income taxes 3,543 27.0% 3,130 22.4% -413 -11.7%

Income taxes 1,001 7.6% 1,150 8.2% 149 14.9%

Minority interest in income 35 0.3% 40 0.3% 5 14.3%

Net income 2,507 19.1% 1,940 13.9% -567 -22.6%

Net income per share -67.17 yen -22.6%

Change

(Amonut)

Change

(%)

296.69 yen 229.52 yen

(Millions of yen)FY3/14 Results FY3/15 Forecasts

FY3/15 Forecast: Sales by Business Segment

25

Amount % Amount %

(Flow-type business)

DS Division (workplace sales) 4,536 34.5% 4,703 33.6% 167 3.7%

HS Division (installation and referral sales) 1,700 12.9% 1,870 13.4% 170 10.0%

SS Division (store event sales) 716 5.4% 769 5.5% 53 7.3%

MS Division (OEM and wholesale sales) 1,079 8.2% 1,375 9.8% 296 27.5%

Operations Division (after-sales services) 284 2.2% 286 2.0% 2 0.9%

EHW systems sales, total 8,315 63.3% 9,003 64.3% 688 8.3%

(Stock-type business)

Cartridges 3,062 23.3% 3,251 23.2% 189 6.2%

(Sales at subsidiaries)

TRIM (Guangzhou) Water & Health Co., Ltd. 51 0.4% 55 0.4% 4 5.8%

PT.SUPER WAHANA TEHNO 254 1.9% 301 2.2% 47 18.5%

(Others) 489 3.7% 498 3.6% 9 2.0%

Total 12,171 92.6% 13,108 93.6% 937 7.7%

Genetic diagnosis 619 4.7% 150 1.1% -469 -75.8%

Regenerative medicine 312 2.4% 720 5.1% 408 130.4%

Electrolyzed water hemodialysis and

MGO measurement42 0.3% 22 0.2% -20 -47.1%

Total 973 7.4% 892 6.4% -81 -8.3%

Consolidated, total 13,144 100.0% 14,000 100.0% 856 6.5%

Change

(%)(Millions of yen)

Wa

te

r H

ea

lth

ca

re

Bu

sin

ess

Me

dic

al

Bu

sin

ess

FY3/14 Results FY3/15 Forecasts Change

(Amount)

50.76 127.70 192.12 256.09 358.62

2.4%

5.8%

8.2%

10.1%

12.9%

18.4%

1.9%

4.6%

6.4%8.0%

10.2%

14.1%

0%

2%

4%

6%

8%

10%

12%

14%

16%

18%

20%

0.00

100.00

200.00

300.00

400.00

500.00

600.00

700.00

FY3/09 FY3/10 FY3/11 FY3/12 FY3/13 FY3/14 FY3/15 (fct.)

Net income per share ROE ROA

296.69 229.52

Pre-split basis

593.38 Pre-split basis

459.04

Aiming to Improve Management Efficiency

26

10.9%

15.4%

17.6%

20.9%22.8%

26.2%

22.4%

0.0%

5.0%

10.0%

15.0%

20.0%

25.0%

30.0%

FY3/09 FY3/10 FY3/11 FY3/12 FY3/13 FY3/14 FY3/15 (fct.)

Ordinary Income to Net Sales

ROE/ROA

* ROE (Net income/ Shareholders' equity)

ROA (Net income/Total assets)

2-for-1 stock split in

October 2013

Initiatives to Enhance Shareholder Value

27

FY3/09 FY3/11FY3/10 FY3/12 FY3/13 FY3/14

50

¥100 equivalent

based on the number

of shares before the

stock split

35

Trend in dividend (Yen)

� Dividend policy: Placing importance on paying stable dividends, while payout ratio to improve gradually

� Shareholder special benefit plan: Discount coupon for Nihon Trim products

50

FY3/15 (fct.)

*April 25, 2014

Announcement of the repurchase of

treasury shares

Issued shares: 50,000 shares

Total acquisition price: ¥250 million

Repurchase period: Apr. 28, 2014 to

Mar. 31, 2015

35

60

30

50 50

70

Dividend

increase

of 15 yen

2-for-1 stock split

in October 2013

*Retirement of 300,000 shares of

treasury share on September 26,

2013

Trend in Consolidated Results of Operations

28

4,573 5,237

6,418

8,808

9,762 10,101

9,650 9,572 8,749

7,963 8,232 8,889

9,617

10,690

13,144

14,000

694 934 1,408

1,922 2,213 2,406 1,783 1,488

929 866 1,265 1,561

2,012 2,440

3,442 3,130

0

3,000

6,000

9,000

12,000

15,000

Net sales Ordinary income

Nov. 2000

Registered on

JASDAQ

Feb. 2003

Listed on TSE 2nd Section

Mar. 2004

Listed on TSE 1st Section

Mar. 2010

Launched TRIM ION NEO

(Millions of yen) Apr. 2014

Launched TRIM ION HYPER

Apr. 2014

Launched TRIM ION HYPER

29

3. Supplementary Materials

The Anti-oxidant Properties of EHW

30

Water samples pH

Oxidation-

reduction

potential (mV)

Dissolved

hydrogen density

(ppb)

Tap water 7.57 564 0

EHW Level 1 9.3 -106 117

EHW Level 2 9.62 -175 211

EHW Level 3 9.96 -210 301

EHW Level 4 10.01 -389 327

Osaka

• Water samples were obtained in Kita-ku,

Osaka

• pH = Hydrogen ion index

= More alkaline as number increases

• Oxidation-reduction potential

= Reduction power increases as voltage

decreases

• ppb = Parts per billion, a measure of density

All figures may change depending on the

location and season.

How EHW eradicates reactive oxygenElectrolysis

Produces oxygen

Electrolyzed acidic

water

Produces hydrogen

EHW

Electrode

Electrode

Ion

exch

an

ge

me

mb

ran

e

Reactive oxygenReduction

Returns to water

after reduction

Active hydrogenImage

Nihon Trim’s Exclusive Technologies

31

Chlorine

Calcium

Potassium

Sodium

Magnesium

Cl－

O2O2

+ electrode - electrodeSeparation

membrane

H2 H2

Electrolyzed

acidic waterEHW

ScaleProduces EHW with

consistent long-term

performance

*Photo shows electrode

coated with a scale

Electrode of a Nihon Trim EHW system

Electrode of alkaline ion water purifier

Stable production of

alkali ion water for

only a short time

*The double auto-change cross-line method

Switching polarity periodically prevents scale from

accumulating on the electrodes, which keeps electrolysis

performance high for a long time.

No need to clean the electrode plates!

An SPA Model for EHW Systems

32

Installation /

Follow-up ServicesSalesR&D / Manufacturing

(Production Factory)

“ISO9001:2008” “ISO13485:2003” 28 sites, approx. 200 sales employees Approx. 0.55 million household customers

Manufacturing Subsidiary

Trim Electric Machinery Co., Ltd.

Sales Company

Nihon Trim Co., Ltd.

Installation Subsidiary

Trim Life Support Co., Ltd.

An integrated business model that covers everything from

manufacturing to sales and customer service

Corporate Social Responsibility

33

● Recycling of used water purification cartridges

● Kochi Business Challenge Fund (the Nihon Trim Fund)

Provide support for start-up businesses (formed with a donation of ¥100 million)

● Sports: Holds Trim Cup and other events

(1) Sponsored by the Japan Futsal Federation:

Trim Cup 2014 6th National Women‘s Invitational Futsal Tournament

(2) Main sponsor of The Kochi Fighting Dogs

(3) Baseball Challenge League sponsor

(4) Official water contract with Orix Buffaloes

(5) Official supplier of Tango university ekiden and Kansai students ekiden relay race

* Supplied to 10 teams in the J League, and approx. 100 sport-related organizations including

professional teams, corporations, universities, and high schools.

● Relay for Life Japan

Support events for cancer patients and their families are sponsored by the Japan

Cancer Society.

We provide “I'm fine” as an official supplier.

FY3/14 Topics

34

■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■

2013 2014

Entered into the

agriculture field

Ran a booth at the

Japanese Society for

Dialysis Therapy

Entered into the

regenerative

medicine field

Relocated Nihon Trim

Headquarters

Opened three

sales officesOpened TrimGen

Osaka Office

The Federation

of Diet Members

was established

6th Trim Cup

7th Electrolyzed Water

Hemodialysis Study

Group Meeting was heldJun.

May Jul.

Aug.

Sep.

Sep.

Mar.

Feb.

Oct.

Corporate Overview

35

Corporate Overview

Main businessManufacture and sale of household EHW system

(healthcare device)

Established June 12, 1982

Headquarters22F, Herbis Ent, 2-2-22 Umeda, Chuo-ku, Osaka, Japan

Tel. +81-(0)6-6456-4600 Fax. +81-(0)6-6455-3951

Capital 992,597,306 yen

SharesListed on the First Section of the Tokyo Stock Exchange

Securities Identification Code: 6788

Issued shares 8,656,780 shares

Shareholders 4,653 (as of the end of March 2014)

Employees 449 (as of the end of March 2014)

President Shinkatsu Morisawa

Main banksSumitomo Mitsui Banking Corporation,

Sumitomo Mitsui Trust Bank, Limited

HERBIS ENT, where the Company’s

headquarters are located

Member of Councillors, Nippon Keidanren

Member, Kansai Economic Federation

Member, Osaka Chamber of Commerce and Industry

Member, Japan Hospital Association

Director, Functional Water Foundation

Nihon Trim Group Companies

36

Water and Health care Business Medical and Genetic Business

Overseas Business

TRIM (Guangzhou) Water & Health Co., Ltd.(Based in China; established in October 2005)

PT SUPER WAHANA TEHNO(Based in Indonesia; invested in October 2006）

ISO：22000：2005

MEDFIRST TRIM CO., LTD.(Based in Taiwan; established in April 2012)

Trim Electric Machinery Co., Ltd.

(Production factory; established in February 1990)

ISO9001: 2008 ISO13485: 2003

Functional Water & Cell Analyzing Center

Co., Ltd.(Measurement and scientific analysis of functional water;

established in April 2004)

Trim Life Support Co., Ltd.(After-sales services; established in February 2012)

Others

TrimGen Corporation(Development of genetic diagnostic kit; established in

January 1999)

ISO9001: 2008

TrimGen Holdings Co., Ltd.(Holding company; established in May 2007)

Trim Medical Institute Co., Ltd.(Contract measurements of glycolytic metabolites and

sales of electrolyzed water hemodialysis system;

established in December 2007)

StemCell Institute Inc.(Private cord blood bank; established in August 1999)

Trim Electric Machinery

(Nankoku city, Kochi prefecture: completed in 2002)